Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Dr. Eric von Hofe, the President of Antigen Express, Inc., its wholly owned immunotherapeutics subsidiary, made an invited presentation this week of the Company’s synthetic avian influenza program at an embassy briefing hosted by Sandler, Travis & Rosenberg, P.A. in Washington, D.C.
